05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Drug delivery agents in the form of dissolvable film that
facilitate the delivery of pharmaceutical preparations,
nutraceuticals and dietary supplements, for medicinal and
dental use; transbuccal patches, trans-mucosal patches, and
patches containing pharmaceutical preparations for oral
local release of pharmaceuticals, for use in the treatment
of dry mouth, mouth ulcers, oral thrush, and mucositis;
transbuccal patches, trans-mucosal patches, and oral
adhesive patches for oral local release of medicated oral
care preparations, vitamin preparations, bacteriostats, and
nutraceuticals, for medicinal and dental use.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Drug delivery agents in the form of dissolvable film that facilitate the delivery of pharmaceutical preparations, nutraceuticals and dietary supplements, for medicinal and dental use; transbuccal patches, trans-mucosal patches, and patches containing pharmaceutical preparations for oral local release of pharmaceuticals, for use in the treatment of dry mouth, mouth ulcers, oral thrush, and mucositis; transbuccal patches, trans-mucosal patches, and oral adhesive patches for oral local release of medicated oral care preparations, vitamin preparations, bacteriostats, and nutraceuticals, for medicinal and dental use
3.
Adhesive oral dissolved films in managing oral care
Disclosed is a dissolvable film adapted to adhere to an oral mucosal tissue of a subject, wherein the film comprises at least three indigestible hydrophilic polymers constituting from 35% to 55% of the film dry weight and wherein the at least three polymers comprise xanthan gum and carboxymethyl cellulose (CMC) in a weight ratio of between 1:0.8-1.6, and at least one other cellulose based polymer. Optionally, the film may further include an active agent in an amount of 0.01% to 35% of the film dry weight. Disclosed also is a method for preparing the film and a method for treating or preventing oral conditions comprising implementing the film. Particularly, the film may be applied between dentures and the gums of the user.
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
A61Q 11/00 - Préparations pour le nettoyage des dents, de la bouche ou des prothèses dentaires, p. ex. dentifricesBains de bouche
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 31/14 - Composés d'ammonium quaternaire, p. ex. édrophonium, choline
A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
A61K 31/131 - Amines, p. ex. amantadine acycliques
A61K 6/35 - Préparations pour la stabilisation de prothèses dentaires dans la bouche
A61K 36/889 - Arecaceae, Palmae ou Palmaceae (famille du palmier), p. ex. dattier ou cocotier ou palmier nain
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
4.
ADHESIVE ORAL DISSOLVED FILMS IN MANAGING ORAL CARE
Disclosed is a dissolvable film adapted to adhere to an oral mucosal tissue of a subject, wherein the film comprises at least three indigestible hydrophilic polymers constituting from 35% to 55% of the film dry weight and wherein the at least three polymers comprise xanthan gum and carboxymethyl cellulose (CMC) in a weight ratio of between 1:0.8-1.6, and at least one other cellulose based polymer. Optionally, the film may further include an active agent in an amount of 0.01% to 35% of the film dry weight. Disclosed also is a method for preparing the film and a method for treating or preventing oral conditions comprising implementing the film. Particularly, the film may be applied between dentures and the gums of the user.
A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif
A61K 47/30 - Composés macromoléculaires organiques ou inorganiques, p. ex. polyphosphates inorganiques
A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
5.
Oral dissolving films for insulin administration, for treating diabetes
Provided are orally administrable thin film dosage forms adapted to adhere to a mucosal tissue of a patient, wherein said film comprises mixtures of polymers and insulin.
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
A61K 47/34 - Composés macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. polyesters, acides polyaminés, polysiloxanes, polyphosphazines, copolymères de polyalkylène glycol ou de poloxamères
Provided are orally administrable thin film dosage forms adapted to adhere to a mucosal tissue of a patient, wherein said film comprises mixtures of polymers and insulin.
